News and Announcements
Imagion Biosystems announces positive results of its clinical trial data
- Published February 16, 2023 6:52AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Imagion Biosystems (ASX: IBX) released this week the results of an independent review of their clinical trial data, which confirms that the company’s targeted imaging agent is safe and detectable by MRI machines. The company also announced it has dosed 9 patients in its Phase 1 HER2 breast cancer study still open for enrollment in four sites across Australia.
Guided by the clinical results, Imagion has decided to prioritize the development of its targeted nanoparticles in conjuncture with the existing MRI technology, as opposed to IBX’s proprietary MRX machines. With this shift in strategy, the company hopes to eliminate the near-term expense and risks associated with developing and introducing a new type of detection technology.
The company held a webinar yesterday to discuss the announcement with shareholders. The recording can be viewed here.
Sharing the full announcement with you to see if we can get an inclusion in WI’s next newsletter. It would be great to include the link to the recording in the company blurb to drive traffic to the site.
Connect with the company and learn more about Imagion Biosystems by accessing their deal room here.
Company Updates
Empowering Capital Raising, Business Sales and Private Market Opportunities
The world of Private Markets is rapidly evolving. As we stand at the crossroads of technology and finance, one thing becomes clear: the age-old ways of raising capital and business sales through limited networks are becoming obsolete. In their place, a more streamlined, efficient, and global pathway to investors is emerging. Enter the Channel Partner […]
Building Awareness Funnel: A Strategic Approach to Strengthening Capital Raise Position
In the competitive landscape of startups, raising capital quickly is a common goal for many founders. However, the desire to move investors rapidly from the awareness stage to the decision stage may not be the most effective way to make a startup well known. Understanding Your Competition Founders must recognise that they will face competition […]
Facing Rejections in Capital Raising: A Guide for Startups
Raising capital is often cited as one of the most formidable challenges that startup founders face. The journey is fraught with rejection, emotional turmoil, and unexpected obstacles. These obstacles are a normal part of the journey, and understanding them can provide valuable insights for entrepreneurs. Going Through Emotions The emotional rollercoaster that accompanies the capital […]
Backed By Leading Investment Groups and Family Offices
